409 related articles for article (PubMed ID: 2141985)
1. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
Monti JM; Fernández M; Jantos H
Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
[TBL] [Abstract][Full Text] [Related]
2. The dopamine D1 receptor is involved in the regulation of REM sleep in the rat.
Trampus M; Ferri N; Monopoli A; Ongini E
Eur J Pharmacol; 1991 Mar; 194(2-3):189-94. PubMed ID: 2060599
[TBL] [Abstract][Full Text] [Related]
3. The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum.
Walters DE; Howard SG
Eur J Pharmacol; 1990 Aug; 184(2-3):257-64. PubMed ID: 2150376
[TBL] [Abstract][Full Text] [Related]
4. Excitatory and inhibitory dopaminergic regulation of oxytocin secretion in the lactating rat: evidence for respective mediation by D-1 and D-2 dopamine receptor subtypes.
Crowley WR; Parker SL; Armstrong WE; Wang W; Grosvenor CE
Neuroendocrinology; 1991 May; 53(5):493-502. PubMed ID: 1831247
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the interaction between D1 and D2 receptors in a drug discrimination paradigm.
Williams JE; Sutherland JV; Woolverton WL
Behav Neural Biol; 1990 May; 53(3):378-92. PubMed ID: 1972014
[TBL] [Abstract][Full Text] [Related]
6. The D1 dopamine receptor antagonist SCH 23390 enhances REM sleep in the rat.
Trampus M; Ongini E
Neuropharmacology; 1990 Oct; 29(10):889-93. PubMed ID: 2147740
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological evaluation of SCH-12679: evidence for an in vivo antagonism of D1-dopamine receptors.
Breese GR; Criswell HE; McQuade RD; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1990 Feb; 252(2):558-67. PubMed ID: 1968972
[TBL] [Abstract][Full Text] [Related]
8. Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat.
Monti JM; Hawkins M; Jantos H; D'Angelo L; Fernández M
Psychopharmacology (Berl); 1988; 95(3):395-400. PubMed ID: 3137628
[TBL] [Abstract][Full Text] [Related]
9. Involvement of D1 receptors in depression-like behavior of ovariectomized rats.
Fedotova J; Ordyan N
Acta Physiol Hung; 2011 Jun; 98(2):165-76. PubMed ID: 21616775
[TBL] [Abstract][Full Text] [Related]
10. The dopamine D1 receptor agonists, A68930 and SKF 38393, induce arousal and suppress REM sleep in the rat.
Trampus M; Ferri N; Adami M; Ongini E
Eur J Pharmacol; 1993 Apr; 235(1):83-7. PubMed ID: 8100197
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the effects of the D1 receptor antagonists SCH 23390 and SCH 39166 on suppression of feeding behavior by the D1 agonist SKF38393.
Terry P; Katz JL
Psychopharmacology (Berl); 1994 Jan; 113(3-4):328-33. PubMed ID: 7862841
[TBL] [Abstract][Full Text] [Related]
12. Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat.
Wachtel SR; Brooderson RJ; White FJ
Psychopharmacology (Berl); 1992; 109(1-2):41-8. PubMed ID: 1365670
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of dopamine receptor involvement in rat feeding behaviour.
Zarrindast MR; Owji AA; Hosseini-Nia T
Gen Pharmacol; 1991; 22(6):1011-6. PubMed ID: 1687390
[TBL] [Abstract][Full Text] [Related]
14. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures.
Turski WA; Cavalheiro EA; Ikonomidou C; Bortolotto ZA; Klockgether T; Turski L
Synapse; 1990; 5(2):113-9. PubMed ID: 2137942
[TBL] [Abstract][Full Text] [Related]
15. Effects of the selective dopamine D-2 receptor agonist, quinpirole on sleep and wakefulness in the rat.
Monti JM; Jantos H; Fernández M
Eur J Pharmacol; 1989 Oct; 169(1):61-6. PubMed ID: 2574689
[TBL] [Abstract][Full Text] [Related]
16. Activation of D1 and D2 dopamine receptors increases the activity of the somatostatin receptor-effector system in the rat frontoparietal cortex.
Izquierdo-Claros RM; del Boyano-Adánez M; Arilla-Ferreiro E
J Neurosci Res; 2000 Oct; 62(1):91-8. PubMed ID: 11002291
[TBL] [Abstract][Full Text] [Related]
17. Discriminative stimulus properties of D1 and D2 dopamine agonists in rats.
Kamien JB; Goldberg LI; Woolverton WL
J Pharmacol Exp Ther; 1987 Sep; 242(3):804-11. PubMed ID: 2958620
[TBL] [Abstract][Full Text] [Related]
18. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR
J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257
[TBL] [Abstract][Full Text] [Related]
20. D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists.
Huang KX; Walters JR
J Pharmacol Exp Ther; 1992 Jan; 260(1):409-16. PubMed ID: 1530977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
